您所在的位置: 首页 >>English >>Academic Trends >>Academic Exchanges >> 正文

English

Academic Exchanges

CD22 CAR-T Cell Therapy Brings New Hope for Efficacy

字号: + - 14

On behalf of Beijing Boren Hospital, Director Jing PAN in the Department of Hematology in our hospital delivered a speech at the 23rd annual conference of the European Hematology Association (EHA) held in Stockholm, Sweden, and reported the results of the clinical study on humanized CD22-CART cell therapy in 15 children with refractory/relapsed B-cell acute lymphoblastic leukemia (B-ALL). The participating experts paid great attention to this study , which was widely reported by domestic and overseas media after the conference.